Glutathione/Inosine

谷胱甘肽/肌苷

Report date: 2022/12/07 17:15:09

Base Information

Drug NameGlutathione/Inosine
Drug Alias Name肌苷/谷胱甘肽Inosine/GlutathioneInosine and GlutathioneGlutathione and InosineMolixan +[7] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionBeta-nerve growth factor stimulants
TargetsBeta-nerve growth factor
Therapy Area/IndicationsHepatitis CHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes InosineGlutathione
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCellectar Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCellectar Biosciences Inc
Inactive CompaniesN/A
Active IndicationsHepatitis CHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeA05A
Related LinksN/A